These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32461964)

  • 21. Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy.
    Kim YG; Choi YW; Kim SY; Moon JY; Ihm CG; Lee TW; Jeong KH; Yang SH; Kim YS; Oh YJ; Lee SH
    Am J Nephrol; 2015; 42(3):250-7. PubMed ID: 26484659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Patients with Idiopathic Membranous Nephropathy.
    Zhang Q; Liu G
    Kidney Blood Press Res; 2024; 49(1):490-494. PubMed ID: 38865986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
    Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
    Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor.
    Zhang Q; Liu X; Zhang Z; Wu M; Huang B; Zhang Y; Liu B; Qi Z; Shan W; Wang L; Hu Z; Sun Z
    Medicine (Baltimore); 2019 Nov; 98(45):e17658. PubMed ID: 31702617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy.
    Wei SY; Wang YX; Li JS; Zhao SL; Diao TT; Wang Y; Wang C; Qin Y; Cao Y; Wei Q; Li B
    Am J Nephrol; 2016; 43(2):129-40. PubMed ID: 27058841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study.
    Pang L; Zhang AM; Li HX; Du JL; Jiao LL; Duan N; Liu Y; Yu D
    Medicine (Baltimore); 2017 Jun; 96(24):e7218. PubMed ID: 28614271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. M-Type Phospholipase A2 Receptor Autoantibody Measured by ELISA has Diagnostic Value in Patients with Idiopathic Membranous Nephropathy.
    Li J; Mulatibieke A; Liu S; Adelibieke Y; Dai C; Chahan S; Chen H
    Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.
    Li X; Wei D; Zhou Z; Wang B; Xu Y; Pan J; Yang C; Lu J; Qiu Y
    Med Sci Monit; 2016 May; 22():1630-6. PubMed ID: 27179439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the status of phospholipase A2 receptor and prognosis of idiopathic membranous nephropathy.
    Li YQ; Liu ZZ; Lin KX; Liu RH; Ni L; Liu GX; Lan HY; Shi YJ
    Nephrology (Carlton); 2020 Feb; 25(2):144-149. PubMed ID: 31226230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.
    Bech AP; Hofstra JM; Brenchley PE; Wetzels JF
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1386-92. PubMed ID: 25035272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis.
    Dong D; Fan TT; Wang YY; Zhang L; Song L; Zhang L
    BMC Nephrol; 2019 Dec; 20(1):444. PubMed ID: 31791262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.
    Kaga H; Komatsuda A; Yamamoto S; Kikuchi T; Kamata M; Sato A; Odaka M; Yokota SI; Takahashi N; Wakui H
    Clin Exp Nephrol; 2019 Apr; 23(4):465-473. PubMed ID: 30756249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
    Pourcine F; Dahan K; Mihout F; Cachanado M; Brocheriou I; Debiec H; Ronco P
    PLoS One; 2017; 12(3):e0173201. PubMed ID: 28257452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy.
    Xie Q; Li Y; Xue J; Xiong Z; Wang L; Sun Z; Ren Y; Zhu X; Hao CM
    Am J Nephrol; 2015; 41(4-5):345-53. PubMed ID: 26087695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
    Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
    Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of anti-phospholipasea2-receptor antibodies with clinical course of idiopathic membranous nephropathy.
    Thokhonelidze I; Maglakelidze N; Sarishvili N; Kasradze T; Dalakishvili K
    Georgian Med News; 2015 Apr; (241):49-53. PubMed ID: 25953939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
    Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: Clinical value assessment.
    Cheng G; Liu J; Gilbert A; Cao Y; An C; Lv Z; Wang C; Nie R; Zhang J; Liu Y; Xia M; Li S; Cai H; Li Y; Li Y; Qin X
    Clin Chim Acta; 2019 Mar; 490():135-141. PubMed ID: 30605630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.